According to GuruFocus Insider Data, these were the largest CEO sells during the past week: Monolithic Power Systems Inc., Five Prime Therapeutics Inc., Nektar Therapeutics Inc. and Southern Co.
Monolithic Power Systems Inc. (MPWR, Financial): CEO Michael Hsing sold 179,265 shares
Hsing sold 179,265 shares during the past week at an average price of $57.93 per share. Monolithic Power Systems is a semiconductor company and was founded in 1997. Monolithic Power Systems has a market cap of $2.24 billion; its shares were traded at around $56.76 with a P/E ratio of 67.63 and P/S ratio of 7.16. The dividend yield of Monolithic Power Systems stocks is 1.41%. Monolithic Power Systems had an annual average earnings growth of 5.50% over the past 10 years.
Monolithic Power Systems Inc. released its 2015 full-year results with net sales of $333.1 million and net earnings of $35.2 million.
Hsing sold 204,839 shares of the stock in November and February. CFO Meera Rao sold 50,414 shares in November and February. Vice President and General Counsel Saria Tseng, Senior Vice President of Sales and Marketing Maurice Sciammas and President of Asia Operations Deming Xiao together sold 61,300 shares in February.
Five Prime Therapeutics Inc. (FPRX, Financial): President and CEO Lewis T. Williams sold 71,229 shares
Williams sold 71,229 shares on Feb. 4 at an average price of $33.35. Five Prime Therapeutics has a market cap of $807.238 million; its shares were traded at around $29.35 with a P/S ratio of 34.14.
Five Prime Therapeutics Inc. declared its 2015 third quarter results with net sales of $5.9 million and net loss of $24 million.
Williams sold 146,229 shares of the stock in September, October and February. Executive Vice President and General Counsel Francis Willard Sarena sold 30,000 shares on Jan. 27 at the average price of $35.22.
Nektar Therapeutics Inc. (NKTR, Financial): President and CEO Howard W. Robin sold 66,666 shares
Robin sold 66,666 shares on Feb. 10 at an average price of $11.49. Nektar Therapeutics was incorporated in July 1990 and reincorporated in Delaware in 1998. Nektar Therapeutics has a market cap of $1.54 billion; its shares were traded at around $11.54 with a P/S ratio of 7.18.
Nektar Therapeutics Inc. reported revenues of $60.0 million and net loss of $8.2 million in its 2015 third quarter results.
Robin sold 508,334 shares of the stock from October to February. Senior Vice President and General Counsel Gil M Labrucherie, Chief Accounting Officer Jillian B. Thomsen, and Director Lutz Lingnau together sold 68,333 shares in January and February.
Southern Co. (SO, Financial): President and CEO Mark A. Crosswhite sold 63,926 shares
Crosswhite sold 63,926 shares on Feb. 4 at an average price of $47.9. Southern Co. has a market cap of $43.55 billion; its shares were traded at around $47.91 with a P/E ratio of 18.38 and P/S ratio of 2.44. The dividend yield of Southern Co. stocks is 4.53%. Southern Co. had an annual average earnings growth of 2.40% over the past 10 years.
Southern Co. announced its 2015 annual results with net revenues of $17.5 billion and net income of $2.4 billion.
Executive Vice President and CFO Art P Beattie sold 140,384 shares of the stock in January and February. Executive Vice President Christopher C Womack, Comptroller Ann P Daiss, and COO Kimberly S. Greene together sold 89,974 shares from October to February.
For the complete list of stocks that were bought by their CEOs, go to: Insider Buys.
